Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 06-2008 | 12-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 2,990 | 8,280 | 12,970 | 2,450 |
| Marketable Securities | N/A | 0 | N/A | 0 | 10,180 |
| Receivables | N/A | 350 | 850 | 920 | 650 |
| Other current assets | 0 | 40 | 10 | 10 | 40 |
| TOTAL | $N/A | $3,380 | $9,140 | $13,900 | $13,320 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 150 | 110 | 100 |
| TOTAL | $N/A | $N/A | $150 | $110 | $100 |
| Total Assets | $N/A | $3,430 | $9,380 | $14,120 | $13,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 410 | 4,230 | 3,800 | 3,130 |
| Accrued Expenses | N/A | 1,050 | N/A | 0 | N/A |
| Other current liabilities | N/A | 530 | 2,240 | 1,560 | 960 |
| TOTAL | $N/A | $2,000 | $6,480 | $5,360 | $4,090 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 150 | 190 | 180 |
| TOTAL | $N/A | $N/A | $150 | $190 | $370 |
| Total Liabilities | $N/A | $2,000 | $6,640 | $5,560 | $4,480 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 1,440 | 1,440 | 1,440 | 1,070 |
| Retained earnings | N/A | -149,100 | -146,970 | -139,860 | -129,570 |
| TOTAL | $N/A | $1,420 | $2,740 | $8,560 | $9,080 |
| Total Liabilities And Equity | $0 | $3,420 | $9,380 | $14,120 | $13,560 |